We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONYX
9301
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
$11 ﹤0.01%
+1
New +$11
PHGE.U
9302
DELISTED
BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock
PHGE.U
$11 ﹤0.01%
4
ACAC
9303
DELISTED
Acri Capital Acquisition Corp
ACAC
$11 ﹤0.01%
+1
New +$11
ANSC
9304
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
$10 ﹤0.01%
+1
New +$10
ATLX icon
9305
Atlas Lithium Corp
ATLX
$80.8M
$10 ﹤0.01%
1
FINW icon
9306
FinWise Bancorp
FINW
$188M
$10 ﹤0.01%
1
-2,510
-100% -$25.7K
TULP
9307
Bloomia Holdings
TULP
$10 ﹤0.01%
2
MBOT icon
9308
Microbot Medical
MBOT
$116M
$10 ﹤0.01%
10
NCPLW icon
9309
Netcapital Inc Warrants
NCPLW
$10 ﹤0.01%
515
-1,632
-76% -$38
SPKLU
9310
Spark I Acquisition Corp Unit
SPKLU
$10 ﹤0.01%
+1
New +$11
USAU icon
9311
US Gold Corp
USAU
$214M
$10 ﹤0.01%
2
-963
-100% -$4.77K
WINT
9312
DELISTED
Windtree Therapeutics
WINT
0
FFAIW
9313
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$10 ﹤0.01%
243
-42
-15% -$1
YOTAR
9314
DELISTED
Yotta Acquisition Corporation Right
YOTAR
$10 ﹤0.01%
118
+28
+31% +$4
JFWD
9315
DELISTED
Jacob Forward ETF
JFWD
$10 ﹤0.01%
+1
New +$10
LEV.WS.A
9316
DELISTED
The Lion Electric Company Warrants to purchase common shares
LEV.WS.A
$10 ﹤0.01%
+63
New +$13
MCACU
9317
DELISTED
Monterey Capital Acquisition Corporation Unit
MCACU
$10 ﹤0.01%
1
CRGOW icon
9318
Freightos Ltd Warrant
CRGOW
$1.73M
$9 ﹤0.01%
+96
New +$12
FCUV icon
9319
Focus Universal
FCUV
$8.15M
-4
Closed -$462
USGOW
9320
DELISTED
U.S. GoldMining Inc Warrant
USGOW
$9 ﹤0.01%
+18
New +$13
XAGEW
9321
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$9 ﹤0.01%
+131
New +$13
CLRCR
9322
DELISTED
ClimateRock Right
CLRCR
$9 ﹤0.01%
93
-977
-91% -$107
GLACR
9323
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$9 ﹤0.01%
+44
New +$10
PRENW
9324
Prenetics Global Ltd Warrant
PRENW
$8 ﹤0.01%
566
+233
+70% +$2
SLND.WS icon
9325
Southland Holdings Warrants
SLND.WS
$1.27M
$8 ﹤0.01%
22
+18
+450% +$6

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.